Stocks
Nektar Therapeutics (NKTR) EV/EBITDA US GAAP (year values) |
|||||||||
| 2022 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -0.15 | 1.07 | 0.73 | -0.45 | -4.75 | -9.94 | ||
| Changes by years, y/y, % | -96% | -802% | -31% | -161% | +967% | -47.0% | |||
Nektar Therapeutics. EV/EBITDA
Nektar Therapeutics. EV/EBITDA, changes, %
Nektar Therapeutics (NKTR) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | 2026Q1 | LTM ? | |||
| EV/EBITDA | ? | -3.26 | -7.20 | -6.19 | -10.7 | -11.3 | -9.94 | |
| Changes by years, y/y, % | -1 484% | +630% | +1 166% | +4 068% | +4 296% | |||
| Changes by quarters, q/q, % | +1 169% | +121% | -14% | +73% | +5% | |||
